Drug profile · INN
alfentanil hydrochloride
ALFENTA
alfentanil hydrochloride (ALFENTA) is a mu opioid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — alfentanil hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
alfentanil hydrochloride (ALFENTA) is a mu opioid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Mu opioid receptor agonist
Primary target: Mu-type opioid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is alfentanil hydrochloride?
alfentanil hydrochloride (ALFENTA) is a mu opioid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for alfentanil hydrochloride?
ALFENTA is a marketed brand name for alfentanil hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of alfentanil hydrochloride?
alfentanil hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.